Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rapport Therapeutics, Inc. | 286,876 | reported | 25 Mar 2026 | tx 6+323,904−12,955 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Mar 2026 | SALE | Rapport Therapeutics, Inc. | 10,115 | 29.99 USD | |
| 02 Feb 2026 | GRANT_AWARD | Rapport Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 9,000 | — | |
| 31 Dec 2025 | SALE | Rapport Therapeutics, Inc. | 2,840 | 30.05 USD | |
| 03 Feb 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 110,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Rapport Therapeutics, Inc. | 84,904 | 0.00 USD | deriv |